What an mRNA melanoma vaccine may mean for cancer treatment
A new mRNA vaccine for melanoma is making headlines. Moderna and Merck recently announced results from their clinical trial suggesting that this new vaccine, in combination with the cancer drug Keytruda, reduced recurrence rates in patients. The companies have not yet released full data from the trial. So, how does…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Science Friday →
Cancer vaccines: Empowering the immune system
The extraordinary promise of personalised cancer vaccines
How mRNA vaccines teach your body to kill cancer; Grim state of climate action; Why birds sing the dawn chorus
The Evolution Of Cancer Treatment
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.